Showing results (11-20 of 25) with videos related to
Sort By:
Pageof 3
Journal of Enzyme Inhibition and Medicinal Chemistry|September 29, 2021
Inhibitors of histone deacetylase 6 based on a novel 3-hydroxy-isoxazole zinc binding groupPasquale Linciano, Luca Pinzi, Silvia Belluti, et al.Cancers|August 12, 2022
Metabolic Pathways as a Novel Landscape in Pancreatic Ductal AdenocarcinomaAhmad Ali, Ugo Chianese, Chiara Papulino, et al.Journal of Translational Medicine|September 23, 2023
Multi-omics analysis reveals attenuation of cellular stress by empagliflozin in high glucose-treated human cardiomyocytesLucia Scisciola, Ugo Chianese, Vicky Caponigro, et al.Cancers|February 4, 2021
Regulatory Interplay between miR-181a-5p and Estrogen Receptor Signaling Cascade in Breast CancerRosaria Benedetti, Chiara Papulino, Giulia Sgueglia, et al.Journal of Enzyme Inhibition and Medicinal Chemistry|March 23, 2022
Heterocycle-containing tranylcypromine derivatives endowed with high anti-LSD1 activityRossella Fioravanti, Veronica Rodriguez, Jonatan Caroli, et al.European Journal of Heart Failure|January 14, 2025
Unlocking the power of empagliflozin: Rescuing inflammation in hyperglycaemia-exposed human cardiomyocytes through comprehensive multi-level analysisRosaria Benedetti, Ugo Chianese, Chiara Papulino, et al.Cell Chemical Biology|December 8, 2023
Irreversible inhibition of TRF2TRFH recruiting functions by a covalent cyclic peptide induces telomeric replication stress in cancer cellsAlexander P Sobinoff, Salvatore Di Maro, Ronnie R J Low, et al.Journal of Experimental & Clinical Cancer Research : CR|October 1, 2025
MiR-423-5p is a metabolic and growth tuner in hepatocellular carcinoma via MALAT-1 and mitochondrial interactionMarco Bocchetti, Alessia Maria Cossu, Manuela Porru, et al.Journal of Translational Medicine|July 23, 2024
Inverse FASN and LDHA correlation drives metabolic resistance in breast cancerChiara Papulino, Ugo Chianese, Ahmad Ali, et al.Signal Transduction and Targeted Therapy|January 19, 2026
Glycolytic heterogeneity drives metabolic-targeted therapy in pancreatic ductal adenocarcinomaUgo Chianese, Chiara Papulino, Gerardo Saggese, et al.Pageof 3